Heat-stable ritonavir approved, ending treatment stranglehold for people living with HIV/AIDSread more
Make It Happen Campaign Update: UNITAID Board still discussing finer details of the Patent Pool Entity read more
New European Parliament Working Group on Innovation & Access launches with support of Access Campaign read more
U.S. health care legislation could limit access read more
MSF responds to World Health Organization’s new HIV treatment guidelines read more
MSF sends letter to EU Ministers of Health regarding antibiotic resistance read more
 |
 |
|
 |
In May 2008, the World Health Assembly agreed on a Global Strategy and Plan of Action aimed at reforming the medical R&D system and enhancing access to medicines for patients in developing countries.
Too often MSF staff find themselves in the painful situation where they don't have adequate medical tools to treat their patients. This is largely because the global system of pharmaceutical Research and Development doesn't developm medicines for diseases that mostly affect poor people.
In May 2008, the World Health Assembly voted through a resolution calling for concrete ways to stimulate innovation into diseases that mainly affect those in developing countries. In this report, produced by Laura McCullagh, patients and MSF doctors explain why urgent change is needed Click here to listen to the audio feature
MSF Clinical Officer Olesi Ellemani Pasulani's reflections on AIDS treatment in Malawi
Living with MDR TB: 'Expert Client' Nonkululeko Mamba's Story
MDR TB Treatment in Cambodia: A Catalyst for Change
